2-((1R,2R,6S,7S)-3,5-Dioxo-4-aza-tricyclo[5.2.1.0(2,6)]dec-4-yl)-N-((1R,9R,10S)-10-hydroxy-12-oxa-8-aza-tricyclo[7.3.1.0(2,7)]trideca-2(7),3,5-trien-4-ylmethyl)-acetamide

ID: ALA4520315

PubChem CID: 155541962

Max Phase: Preclinical

Molecular Formula: C23H27N3O5

Molecular Weight: 425.49

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(CN1C(=O)[C@@H]2[C@@H]3CC[C@@H](C3)[C@@H]2C1=O)NCc1ccc2c(c1)[C@H]1C[C@@H](N2)[C@H](O)CO1

Standard InChI:  InChI=1S/C23H27N3O5/c27-17-10-31-18-7-16(17)25-15-4-1-11(5-14(15)18)8-24-19(28)9-26-22(29)20-12-2-3-13(6-12)21(20)23(26)30/h1,4-5,12-13,16-18,20-21,25,27H,2-3,6-10H2,(H,24,28)/t12-,13+,16-,17-,18-,20-,21+/m1/s1

Standard InChI Key:  BOGJVTQQRCPUBE-RMVSDHFHSA-N

Molfile:  

 
     RDKit          2D

 37 42  0  0  0  0  0  0  0  0999 V2000
   32.5923  -13.8536    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.3098  -13.4424    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.3054  -12.6101    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.5895  -12.2011    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.8774  -13.4389    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.8794  -12.6183    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.1728  -12.2039    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.4571  -12.6116    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.4551  -13.4324    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.1644  -13.8495    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   29.7364  -13.0171    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.7391  -12.1930    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.4547  -11.7812    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   29.0208  -13.4288    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   34.0174  -12.1961    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.7342  -12.6060    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   35.4462  -12.1879    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.1630  -12.5978    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.4457  -11.3639    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   36.8792  -12.1838    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   37.6314  -12.5122    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.9610  -11.3560    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.7690  -11.1823    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.1796  -11.8954    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.0002  -11.8983    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.4153  -11.1823    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.0005  -10.4691    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.1748  -10.4679    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.8130  -13.3195    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   36.3476  -10.8083    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   38.8870  -10.8785    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.4949  -14.2590    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   31.1160  -11.3828    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   39.4166  -12.6114    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   38.0949   -9.6460    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   38.5277  -12.6467    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   37.5864  -10.3772    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
  5  1  1  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  6  1  0
  5  6  2  0
  5 10  1  0
  6  7  1  0
  7  8  1  0
  9  8  1  0
  9 10  1  0
  9 11  1  0
  7 13  1  0
 11 12  1  0
 12 13  1  0
 11 14  1  6
  3 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 17 19  2  0
 18 20  1  0
 20 21  1  0
 24 21  1  0
 23 22  1  0
 22 20  1  0
 23 24  1  0
 23 28  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 21 29  2  0
 22 30  2  0
 28 31  1  0
 25 31  1  0
  9 32  1  6
  7 33  1  6
 25 34  1  6
 28 35  1  6
 24 36  1  6
 23 37  1  6
M  END

Alternative Forms

  1. Parent:

    ALA4520315

    ---

Associated Targets(Human)

PPID Tchem Peptidyl-prolyl cis-trans isomerase D (111 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 425.49Molecular Weight (Monoisotopic): 425.1951AlogP: 0.95#Rotatable Bonds: 4
Polar Surface Area: 107.97Molecular Species: NEUTRALHBA: 6HBD: 3
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 13.78CX Basic pKa: 2.87CX LogP: -0.42CX LogD: -0.42
Aromatic Rings: 1Heavy Atoms: 31QED Weighted: 0.62Np Likeness Score: -0.12

References

1. Grädler U, Schwarz D, Blaesse M, Leuthner B, Johnson TL, Bernard F, Jiang X, Marx A, Gilardone M, Lemoine H, Roche D, Jorand-Lebrun C..  (2019)  Discovery of novel Cyclophilin D inhibitors starting from three dimensional fragments with millimolar potencies.,  29  (23): [PMID:31635932] [10.1016/j.bmcl.2019.126717]
2. Gaali, Steffen S, Kozany, Christian C, Hoogeland, Bastiaan B, Klein, Marielle M and Hausch, Felix F.  2010-12-09  Facile synthesis of a fluorescent cyclosporin a analogue to study cyclophilin 40 and cyclophilin 18 ligands.  [PMID:24900244]
3. Shore, Emma R ER and 12 more authors.  2016-03-24  Small Molecule Inhibitors of Cyclophilin D To Protect Mitochondrial Function as a Potential Treatment for Acute Pancreatitis.  [PMID:26950392]
4. Valasani, Koteswara Rao KR and 8 more authors.  2016-03-10  Identification of a Small Molecule Cyclophilin D Inhibitor for Rescuing Aβ-Mediated Mitochondrial Dysfunction.  [PMID:26985318]

Source